Cetirizine is considered compatible with breastfeeding. The amount that passes into breast milk is well below established safety thresholds, and no serious adverse effects have been reported in nursing infants whose mothers take it at standard doses.
How Much Reaches Your Baby
The key metric pharmacologists use to evaluate drug safety during breastfeeding is the relative infant dose, or RID. This represents the percentage of the mother’s dose (adjusted for weight) that the infant receives through breast milk. Drugs with an RID below 10% are generally classified as compatible with breastfeeding by the WHO Working Group on Drugs and Human Lactation.
For cetirizine, the mean RID is about 2%, with the highest recorded value at peak milk concentration reaching only 3.36%. Even in the most extreme individual case measured, the RID topped out at 5.21%, still well under the 10% cutoff. A 2024 pharmacokinetic modeling study confirmed these numbers across multiple mother-infant pairs, finding a range of 1.02% to 3.53% at average milk concentrations. In practical terms, your baby is exposed to a very small fraction of the drug.
What Side Effects Have Been Reported
In a study of 31 women taking cetirizine (mostly at the standard 10 mg daily dose), 61% reported no adverse effects in their infants at all. The remaining mothers noted minor issues like sedation, poor feeding, rash, or fussiness, but they themselves attributed these to unrelated causes such as colds, teething, learning to crawl, or weaning. None of the reported effects required medical attention.
A broader telephone follow-up study looking at various antihistamines during breastfeeding found that about 10% of mothers reported irritability or colicky symptoms in their infants, and drowsiness showed up in roughly 1.6%. Again, none of those reactions were serious enough to need treatment. These numbers come from antihistamines as a group, not cetirizine specifically, and the rates are low enough that some overlap with normal infant fussiness is likely.
Potential Effects on Milk Supply
There have been occasional reports of reduced milk supply with cetirizine, though the evidence is limited and inconsistent. Older, first-generation antihistamines (the kind that cause significant drowsiness) have a stronger theoretical link to supply issues because high doses of some of those drugs can lower prolactin, the hormone that drives milk production. Cetirizine is a second-generation antihistamine with much less of that sedating, central nervous system activity, so the risk to supply is considered lower.
If you notice a dip in your milk production after starting cetirizine, it’s worth considering the medication as a possible factor. But for most women, standard doses do not cause a noticeable change.
How Cetirizine Compares to Other Allergy Medications
Cetirizine, loratadine, and fexofenadine are all second-generation antihistamines, and all three are considered compatible with breastfeeding. None of them passes into breast milk in amounts large enough to cause meaningful effects in nursing infants at standard doses. A review in Canadian Family Physician concluded that maternal use of loratadine, its active metabolite desloratadine, or fexofenadine at normal therapeutic doses is unlikely to cause adverse effects in breastfed infants.
Loratadine has a slightly longer track record of study during lactation, which is why some references list it as a first-line choice. But cetirizine’s safety profile is comparable, and choosing between them often comes down to which one controls your symptoms better. Fexofenadine is another reasonable option with minimal milk transfer.
First-generation antihistamines like diphenhydramine (Benadryl) are also used during breastfeeding, but they’re more likely to cause drowsiness in both you and your baby. Short-term or occasional use is not considered a major concern, but the newer options are generally preferred for regular allergy control.
Practical Tips for Taking Cetirizine While Nursing
Stick to the standard dose of 10 mg once daily. The research confirming a low RID is based primarily on this dose. Cetirizine typically reaches its peak blood concentration about one to two hours after you take it, and milk levels follow a similar curve. If you want to minimize even the small amount your baby receives, taking your dose right after a feeding session gives the drug time to peak and begin declining before the next feed. That said, with an RID under 4% even at peak levels, this timing strategy is more of a precaution than a necessity.
Watch for unusual drowsiness, irritability, or feeding changes in your baby after you start taking cetirizine. These are uncommon, and even when reported they tend to be mild and self-limiting. Younger infants, especially newborns and preemies, metabolize drugs more slowly, so extra attentiveness in the first few weeks of life is reasonable.